Evidence map›Paper›PMID 41594071›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Clinical Outcomes and Predictors of Mortality in Patients with Difficult-to-Treat Resistant

Alberto Enrico Maraolo, Antonella Gallicchio, Vincenzo Fotticchia, Maria Rosaria Catania, Riccardo Scotto, Ivan Gentile

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Factors governing the response ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alberto Enrico MaraoloSection of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.ORCID 0000-0002-7218-7762
Antonella GallicchioSection of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.ORCID 0000-0002-7274-2068
Vincenzo FotticchiaSection of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.ORCID 0009-0007-0723-495X
Maria Rosaria CataniaDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Napoli, Italy.ORCID 0000-0002-8765-137X
Riccardo ScottoSection of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.ORCID 0000-0002-0178-2986
Ivan GentileSection of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.ORCID 0000-0002-5199-8451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

30-day mortalityceftazidime-avibactamceftolozane-tazobactamclinical outcomesdifficult-to-treat resistant Pseudomonas aeruginosaseptic shocksource control

Identifiers

PMID41594071
PMCPMC12837929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.